| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Pediatric Endocrinology |
Department of Pediatrics, Division of Endocrinology (A.B., M.E., S.M.K.-S.) and Division of Clinical Chemistry (G.B.), Sophia Children’s Hospital, Department of Nuclear Medicine (E.P.), Dijkzigt Hospital, Erasmus University, 3015 GJ Rotterdam, the Netherlands
Address all correspondence and requests for reprints to: A. M. Boot, Sophia Children’s Hospital, Division of Endocrinology, dr. Molewaterplein 60, 3015 GJ Rotterdam, the Netherlands.
Adults with childhood onset GH deficiency (GHD) have reduced bone mass, increased fat mass, and disorders of lipid metabolism. The aim of the present study was to evaluate bone mineral density (BMD), bone metabolism, body composition, and lipid metabolism in GHD children before and during 2–3 yr of GH treatment (GHRx). Forty children with GHD, mean age 7.9 yr, participated in the study of bone metabolism and body composition; and an additional group of 17 GHD children, in the study of lipid metabolism. Lumbar spine BMD, total body BMD, and body composition were measured with dual-energy x-ray absorptiometry. Volumetric BMD (bone mineral apparent density, BMAD) was calculated to correct for bone size. BMD, BMAD, lean tissue mass, bone mineral content, fat mass, and percentage body fat were expressed as SD scores (SDS), in comparison with normative data of the same population. Lumbar spine BMD and BMAD and total body BMD were all decreased at baseline. All BMD variables increased significantly during GHRx, lumbar spine BMD SDS, already after 6 months of treatment. Lean tissue mass SDS increased continuously. Bone mineral content SDS started to increase after 6 months GHRx. Fat mass SDS decreased during the first 6 months of GHRx and remained stable thereafter. Biochemical parameters of bone formation and bone resorption did not differ from normal at baseline and increased during the first 6 months of GHRx. Serum 1,25 dihydroxyvitamin D increased continuously during GHRx, whereas PTH and serum calcium remained stable. Lipid profile was normal at baseline. Atherogenic index had decreased and apolipoprotein A1 (Apo-A1) had increased after 3 yr of treatment.
In conclusion, children with GHD have decreased bone mass. BMD, together with height and lean tissue mass, increased during GHRx. GHRx had a beneficial effect on lipid metabolism.
This article has been cited by other articles:
 |
|
 |
|
  T. S. Hannon, K. Danadian, C. Suprasongsin, and S. A. Arslanian Growth Hormone Treatment in Adolescent Males with Idiopathic Short Stature: Changes in Body Composition, Protein, Fat, and Glucose Metabolism J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3033 - 3039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Abrams and G. J. Strewler Adolescence: How Do We Increase Intestinal Calcium Absorption to Allow for Bone Mineral Mass Accumulation? IBMS BoneKEy, May 1, 2007; 4(5): 147 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Ciresi, M C Amato, A Criscimanna, A Mattina, C Vetro, A Galluzzo, G D'Acquisto, and C Giordano Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency Eur. J. Endocrinol., March 1, 2007; 156(3): 353 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Salerno, V. Esposito, V. Farina, G. Radetti, A. Umbaldo, D. Capalbo, L. Spinelli, S. Muzzica, G. Lombardi, and A. Colao Improvement of Cardiac Performance and Cardiovascular Risk Factors in Children with GH Deficiency after Two Years of GH Replacement Therapy: An Observational, Open, Prospective, Case-Control Study J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1288 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Jarfelt, H Fors, B Lannering, and R Bjarnason Bone mineral density and bone turnover in young adult survivors of childhood acute lymphoblastic leukaemia Eur. J. Endocrinol., February 1, 2006; 154(2): 303 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J H Davies, B A J Evans, and J W Gregory Bone mass acquisition in healthy children Arch. Dis. Child., April 1, 2005; 90(4): 373 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Malerba, S. Bossoni, A. Radaeli, E. Mori, S. Bonadonna, A. Giustina, and C. Tantucci Growth Hormone Response to Growth Hormone-Releasing Hormone Is Reduced in Adult Asthmatic Patients Receiving Long-term Inhaled Corticosteroid Treatment Chest, February 1, 2005; 127(2): 515 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schweizer, D. D. Martin, C. P. Schwarze, G. Binder, A. Georgiadou, J. Roth, and M. B. Ranke Authors' Response: Cortical Bone Density Is Normal in Prepubertal Children with Growth Hormone (GH) Deficiency, but Initially Decreases during GH Replacement due to Early Bone Remodeling J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2505 - 2505. [Full Text] [PDF]
|
|
|
|
|
|
M. Lange, U. Feldt-Rasmussen, O. L. Svendsen, K. W. Kastrup, A. Juul, and J. Muller High Risk of Adrenal Insufficiency in Adults Previously Treated for Idiopathic Childhood Onset Growth Hormone Deficiency J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5784 - 5789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Boot Body Composition and Bone Mineral Density in Adolescents with Partial Growth Hormone Deficiency J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5099 - 5100. [Full Text] [PDF]
|
|
|
|
|
|
M. Tauber, B. Jouret, A. Cartault, N. Lounis, M. Gayrard, C. Marcouyeux, C. Pienkowski, I. Oliver, P. Moulin, P. Otal, et al. Adolescents with Partial Growth Hormone (GH) Deficiency Develop Alterations of Body Composition after GH Discontinuation and Require Follow-Up J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5101 - 5106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schweizer, D. D. Martin, C. P. Schwarze, G. Binder, A. Georgiadou, J. Ihle, and M. B. Ranke Cortical Bone Density Is Normal in Prepubertal Children with Growth Hormone (GH) Deficiency, but Initially Decreases during GH Replacement due to Early Bone Remodeling J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5266 - 5272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Benbassat, V. Eshed, M. Kamjin, and Z. Laron Are Adult Patients with Laron Syndrome Osteopenic? A Comparison between Dual-Energy X-Ray Absorptiometry and Volumetric Bone Densities J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4586 - 4589. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wickman, E. Kajantie, and L. Dunkel Effects of Suppression of Estrogen Action by the P450 Aromatase Inhibitor Letrozole on Bone Mineral Density and Bone Turnover in Pubertal Boys J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3785 - 3793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Hoos, K. R. Westerterp, and W.-J. M. Gerver Short-Term Effects of Growth Hormone on Body Composition as a Predictor of Growth J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2569 - 2572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I M van der Sluis, M A J de Ridder, A M Boot, E P Krenning, S M P F de Muinck Keizer-Schrama, and Z. Mughal Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults Arch. Dis. Child., October 1, 2002; 87(4): 341 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. I. Baroncelli, S. Bertelloni, F. Sodini, and G. Saggese Lumbar Bone Mineral Density at Final Height and Prevalence of Fractures in Treated Children with GH Deficiency J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3624 - 3631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. van der Sluis, A. M. Boot, E. P. Krenning, S. L. S. Drop, and S. M. P. F. de Muinck Keizer-Schrama Longitudinal Follow-Up of Bone Density and Body Composition in Children with Precocious or Early Puberty before, during and after Cessation of GnRH Agonist Therapy J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 506 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Mericq, H. Gajardo, M. Eggers, A. Avila, and F. Cassorla Effects of Treatment with GH Alone or in Combination with LHRH Analog on Bone Mineral Density in Pubertal GH-Deficient Patients J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 84 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Coutant, F. Boux de Casson, S. Rouleau, O. Douay, E. Mathieu, M. Audran, and J. M. Limal Body Composition, Fasting Leptin, and Sex Steroid Administration Determine GH Sensitivity in Peripubertal Short Children J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5805 - 5812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Drake, S. J. Howell, J. P. Monson, and S. M. Shalet Optimizing GH Therapy in Adults and Children Endocr. Rev., August 1, 2001; 22(4): 425 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Soyka, W. P. Fairfield, and A. Klibanski Hormonal Determinants and Disorders of Peak Bone Mass in Children J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 3951 - 3963. [Full Text]
|
|
|
|
|
|
T. Sas, P. Mulder, and A. Hokken-Koelega Body Composition, Blood Pressure, and Lipid Metabolism before and during Long-Term Growth Hormone (GH) Treatment in Children with Short Stature Born Small for Gestational Age Either with or without GH Deficiency J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3786 - 3792. [Abstract] [Full Text]
|
|
|
|
|
|
Degree of Fatness after Treatment for Acute Lymphoblastic Leukemia in Childhood J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4591 - 4596. [Abstract] [Full Text]
|
|
|
|
|
|
J. Svensson, J.-O. Jansson, M. Ottosson, G. Johannsson, M.-R. Taskinen, O. Wiklund, and B.-A. Bengtsson Treatment of Obese Subjects with the Oral Growth Hormone Secretagogue MK-677 Affects Serum Concentrations of Several Lipoproteins, But Not Lipoprotein(a) J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2028 - 2033. [Abstract] [Full Text]
|
|
|
|
|
|
R. Kuromaru, H. Kohno, N. Ueyama, H. M. S. Hassan, S. Honda, and T. Hara Long-Term Prospective Study of Body Composition and Lipid Profiles during and after Growth Hormone (GH) Treatment in Children with GH Deficiency: Gender-Specific Metabolic Effects J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3890 - 3896. [Abstract] [Full Text]
|
|
|
|
|
|
G. I. Baroncelli, S. Bertelloni, C. Ceccarelli, and G. Saggese Measurement of Volumetric Bone Mineral Density Accurately Determines Degree of Lumbar Undermineralization in Children with Growth Hormone Deficiency J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3150 - 3154. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. H. A. Ruvalcaba and G. B. Kletter Abdominal Lipohypertrophy Caused by Injections of Growth Hormone: A Case Report Pediatrics, August 1, 1998; 102(2): 408 - 410. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Boot, S. M. P. F. d. M. Keizer-Schrama, H. A. P. Pols, E. P. Krenning, and S. L. S. Drop Bone Mineral Density and Body Composition before and during Treatment with Gonadotropin-Releasing Hormone Agonist in Children with Central Precocious and Early Puberty J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 370 - 373. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
